Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036944 · ClinicalTrials.gov registry record
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
A clinical trial, sponsored by Providence Medical Research Center.
- Terminated
- Registry status
- 13
- Enrollment target
NCT02036944: Clinical Trial study, sponsored by Providence Medical Research Center.
NCT02036944 is a clinical trial that was terminated before completion, run by Providence Medical Research Center. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02036944 was terminated before completion, sponsored by Providence Medical Research Center.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients with unexplained iron deficiency have underlying diseases processes such as celiac disease. It is hypothesized that selectively screening patients with unexplained iron deficiency will reveal previously undiagnosed etiologies, including celiac disease and other causes of iron malabsorption along with various sources of occult GI blood loss.
Primary Outcome
Expanded Celiac Disease Panel includes TTG-IgG, TTG-IgA, AntiGliadin-IgG, AngtiGliadin-IgA, and Total Serum IgA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-01 |
Why NCT02036944 stopped before completion
NCT02036944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02036944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02036944 about?
NCT02036944 is a clinical study titled "Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting". The purpose of this study is to determine if patients with unexplained iron deficiency have underlying diseases processes such as celiac disease. It is hypothesized that selectively screening patients with unexplained iron deficiency will reveal previously undiagnosed etiologies, including celiac d...
What is the current status of trial NCT02036944?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2014-03. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02036944?
This trial is sponsored by Providence Medical Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia